nimacimab glp-1 news Obesity — Skye Bioscience GLP-1 Pipeline Update: August 2025
Description
Other studies using rodents or primates with immunofluorescent reporter GLP-1Rs verify the expression of GLP-1Rs by pyramidal (glutamergic), GABAergic and catecholaminergic neurons in feeding, energy homeostasis, fear, stress, motivation/reward, learning plus memory as well as Alzheimers disease (AD) and Parkinsons Disease (PD)-associated key brain areas, such as the hippocampus, hypothalamus, cortex, striatum, amygdala, SNpc, or ventral tegmental area (VTA) (Cork et al., 2015

Gastric Effects: Higher systemic drug levels from injections produce stronger effects on stomach emptying and satiety signaling
"But the reality is weight loss is complicated, and it's not about willpower
Cardiovascular risk factors in restless legs syndrome
